HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.80005
-0.0005 (-0.07%)
Nov 13, 2026, 2:28 PM EST - Market open
HCW Biologics Employees
HCW Biologics had 35 employees as of December 31, 2025. The number of employees decreased by 1 or 2.78% compared to the previous year. That makes HCW Biologics the 36,541st largest employer in the world and 5,032nd in the United States.
Employees
35
Change (1Y)
-1
Growth (1Y)
-2.78%
Revenue / Employee
$192,034
Profits / Employee
-$611,719
Market Cap
1.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 35 | -1 | -2.78% |
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Curis | 24 |
| VivoSim Labs | 15 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Revelation Biosciences | 9 |
| Eocene | 6 |
| Jupiter Neurosciences | 5 |
HCWB News
- 7 days ago - HCW Biologics' Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer - GlobeNewsWire
- 7 days ago - HCW Biologics Presents Newly Identified Distinctive Features of Its Lead T Cell Engager Candidate Built with Company's Proprietary T-Cell Engager Platform, Further Supporting Its Use in Treating Solid Tumors at the Society for Immunotherapy of Cancer's 41st Annual Meeting - GlobeNewsWire
- 8 days ago - HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing - GlobeNewsWire
- 5 weeks ago - HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors - GlobeNewsWire
- 5 weeks ago - HCW Biologics registers to sell 1.81M shares of common stock for holders - TheFly
- 6 weeks ago - HCW Biologics Registration statement: Registration filing - Filings
- 6 weeks ago - HCW Biologics Proxy statement: Proxy filing - Filings
- 7 weeks ago - HCW Biologics prices 903,614 units at $1.6599 in private placement - TheFly